Target intelligence / Profile preview

Phagocyte activation

Molecular classification
Other (process/state), Involves multiple classes such as receptors (e.g., Fcγ receptors, complement receptors, pattern-recognition receptors), signaling molecules, and enzymes
01

Overview

Phagocyte activation describes the state in which immune cells known as phagocytes (macrophages, neutrophils, dendritic cells, monocytes) become functionally primed or stimulated, typically in response to infectious or inflammatory signals. This priming occurs via the recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) through pattern-recognition receptors (PRRs), Fcγ receptors, complement receptors, or other opsonic and non-opsonic receptors. Upon activation, phagocytes increase surface expression of adhesion molecules and phagocytic receptors, enhance their microbicidal and metabolic activity, produce inflammatory cytokines, and migrate to sites of infection or injury, where they ingest and degrade pathogens and cell debris. Overactivation can lead to collateral tissue damage, while insufficient activation compromises host defense.

Other names
Phagocyte primingactivation of phagocytosisstimulated phagocytesinflammatory activation of phagocytes
02

Mechanism of action

Inhibition or upregulation of surface receptors (FcγR, complement receptors); modulation of intracellular signaling pathways (e.g., Rho GTPase, PI3K, PKC); modulation of cytokine production; and suppression/activation of actin cytoskeletal rearrangement.

03

Biological functions

Immune responseClearance of pathogens and debrisInflammation initiation and regulationCytokine productionChemotaxis
04

Disease associations

InfectionInflammationSepsisChronic inflammatory diseasesAutoimmune diseaseCancer (tumor-associated macrophage activation)Tissue damage and repair
05

Safety considerations

Excessive activation leads to tissue damage and inflammation (e.g., autoimmune diseases, sepsis, acute respiratory distress syndrome)Impaired function increases risk of infectionModulation can result in immunosuppression or susceptibility to pathogens
06

Interacting drugs

Glucocorticoids (dexamethasone, prednisolone; suppress phagocyte activation)

3 more in the full profile.

07

Biomarkers

Surface markers: CD11b, CD14 (associated with activated phagocytes)Pro-inflammatory cytokines (IL-1β, TNF-α, IL-6)Oxidative burst (reactive oxygen species production)Expression of Fcγ receptors, complement receptors

Beyond the preview

Go deeper on Phagocyte activation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phagocyte activation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call